Abstract
Because Alzheimer's disease (AD) is a medical problem characterized by progressive loss of memory and cognition that is associated with a deficient cholinergic system, this work aims to evaluate some p-aminobenzoic acid (PABA) derivatives as acetylcholinesterase inhibitors in vitro, in continuation with our last studies. The assayed compounds are low toxic, simple-structured and low cost.
Original language | English (US) |
---|---|
Pages (from-to) | 732-735 |
Number of pages | 4 |
Journal | European Journal of Medicinal Chemistry |
Volume | 40 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2005 |
Bibliographical note
Funding Information:The authors thank CONACYT and CGPI for financial support. L.M.E.F. thanks the Ministry of Education of the Slovak Republic for the fellowship granted during the academic year 2003–2004.
Keywords
- Acetylcholine
- Acetylcholinesterase
- Amides
- Enzymatic inhibitors
- Imides
- Molecular docking